Clinical Trials Directory

Trials / Completed

CompletedNCT04585854

Effect of Caffeine on Myocardial Oxygenation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Insel Gruppe AG, University Hospital Bern · Academic / Other
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to investigate the impact of caffeine on myocardial oxygenation and other cardiovascular magnetic resonance parameters in healthy controls.

Detailed description

Caffeine is presumed to create a confounder with diagnostic imaging. The vasodilatory capacity is considered a key measure for the detection of significant coronary disease with stenosed epicardial arterial conduit vessels and overall microvascular function, including endothelial dysfunction. Twenty nine healthy controls will undergo a baseline cardiovascular magnetic resonance (CMR) exam. Afterwards, participants will consume coffee in the presence of study personnel. This will consist of 3 espresso shots, which will be consumed within 15 minutes. Approximately 2h after coffee consumption the CMR exam will be repeated. The goal will be to investigate the impact of caffeine on myocardial features. In particular the effect on the myocardial oxygenation response to vasodilating and vasoconstricting stimuli.

Conditions

Interventions

TypeNameDescription
OTHERCaffeineConsumption of 3 shots of espresso

Timeline

Start date
2020-11-13
Primary completion
2021-10-23
Completion
2021-10-23
First posted
2020-10-14
Last updated
2021-10-26

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04585854. Inclusion in this directory is not an endorsement.